Alps Advisors Inc Arrowhead Pharmaceuticals, Inc. Transaction History

Alps Advisors Inc

$17.2 Billion
Q2 2025

A detailed history of Alps Advisors Inc transactions in Arrowhead Pharmaceuticals, Inc. stock. As of the latest transaction made, Alps Advisors Inc holds 74,497 shares of ARWR stock, worth $2.87 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

74,497

Holding current value

$2.87 Million

% of portfolio

0.01%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 11, 2025	BUY	$9.99 - $16.97 $744,225 - $1.26 Million	74,497 New	74,497 $1.18 Million
Q1 2023 May 10, 2023	SELL	$23.68 - $38.51 $11,129 - $18,099	-470 Reduced 0.65%	71,363 $1.81 Million
Q4 2022 Feb 14, 2023	BUY	$28.0 - $40.56 $392,196 - $568,123	14,007 Added 24.22%	71,833 $2.91 Million
Q3 2022 Nov 14, 2022	SELL	$29.63 - $48.31 $145,305 - $236,912	-4,904 Reduced 7.82%	57,826 $1.91 Million
Q2 2022 Aug 11, 2022	BUY	$27.79 - $50.61 $1.74 Million - $3.17 Million	62,730 New	62,730 $2.21 Million
Q4 2020 Feb 03, 2021	SELL	$43.82 - $85.37 $5.72 Million - $11.1 Million	-130,451 Closed	0 $0
Q3 2020 Nov 04, 2020	SELL	$33.21 - $51.27 $278,631 - $430,155	-8,390 Reduced 6.04%	130,451 $5.62 Million
Q2 2020 Aug 05, 2020	BUY	$26.12 - $43.27 $3.63 Million - $6.01 Million	138,841 New	138,841 $6 Million
Q1 2020 May 06, 2020	SELL	$20.56 - $63.12 $243,492 - $747,530	-11,843 Closed	0 $0
Q4 2019 Feb 07, 2020	SELL	$28.14 - $73.01 $14,463 - $37,527	-514 Reduced 4.16%	11,843 $751,000
Q3 2019 Nov 04, 2019	SELL	$26.26 - $34.86 $1.85 Million - $2.46 Million	-70,499 Reduced 85.09%	12,357 $348,000
Q2 2018 Jul 25, 2018	SELL	$6.37 - $14.02 $213,688 - $470,314	-33,546 Reduced 28.82%	82,856 $305,000
Q1 2018 May 01, 2018	BUY	$3.72 - $7.64 $124,791 - $256,291	33,546 Added 40.49%	116,402 $839,000
Q4 2017 Feb 05, 2018	BUY	$3.14 - $4.5 $260,167 - $372,852	82,856	82,856 $305,000

Others Institutions Holding ARWR

# of Institutions

327

Shares Held

99.7M

Call Options Held

444K

Put Options Held

568K

View Full List

About ARROWHEAD PHARMACEUTICALS, INC.

Ticker ARWR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,849,000
Market Cap $4.07B
Description
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...

More about ARWR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Alps Advisors Inc, based on Form 13F filings with the SEC.

News

Stay updated on Alps Advisors Inc with notifications on news.

Account

Alps Advisors Inc Arrowhead Pharmaceuticals, Inc. Transaction History